Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How do we see bacteria

13.10.2004


Understanding how the body’s immune system recognises and responds to microorganisms can be a major step in the development of new therapies against infectious diseases. Towards this aim, a paper just released in the October issue of Embo reports1 discusses the process used by mammals to respond to bacteria such as Helicobacter pylori, Listeria monocytogenes and Streptococcus pneumoniae which are responsible for ulcers, Listeriosis and pneumonia, respectively.
In order to protect against infection it is necessary to detect invading microorganisms/ microbes capable of inducing disease. This is done through the recognition by the immune system of molecules unique to these invading organisms. In bacteria for example, components of their cell walls such as peptidoglycan, a polymer of sugars and peptides which is involved in cells shape and wall integrity, is one such target. The innate immune system is the first line of defence as it can be mobilised almost immediately and have a crucial role in prevention of infection. But the molecules/receptors and the mechanism involved in the recognition and clearance of microrganisms by this part of the immune system are still poorly known. Toll-like receptors (TLRs) are a family of molecules which have recently emerged as key components in the recognition of infectious agents by the innate immune system.

Now, Leonardo Travassos and Ivo G Boneca from the Institute Pasteur, Paris, France together with colleagues from the Federal University of the Rio de Janeiro, Rio de Janeiro, Brasil and the University Paris-Sud, in Orsay, France, found that TLR2, a member of the TRL family seems to recognise lipoteichoic acid (LTA) an important component of the bacteria cell wall, but does not recognize peptidoglycans, a result in clear disagreement with previous work by other groups. The differences found are due, according to Travassos, Boneca and colleagues, to contamination of the bacteria used in earlier research.


Before Travassos, Boneca and colleagues’ work it was believed that peptidoglycans were recognised through two different type of receptors; TRL2, which is present on the surface of cells of the immune system and by a family of molecules found in the intracellular space called nucleotide-binding oligomerization domain (NOD) a redundancy of roles that did not make much sense. What the team of scientists’ results show is that in fact the immune system uses these two recognition systems to target different molecules on the bacteria wall, the recognition mechanisms probably acting synergistically and so leading to a more powerful immune response and higher probability of getting rid of infection.

These are important results as detailed knowledge of the molecules and pathways involved in the control of the immune system during infection and inflammation opens the door to new highly selective therapeutics. Furthermore, the discovery that TRL2 seems to recognise LTA is extremely interesting as LTA only exists in the cell wall of Gram-positive bacteria (so called because they become positively coloured with Gram stain) and the initial steps of the innate immune response against this type of bacteria are still poorly understood. This is of great significance as Gram-positive bacteria are extremely important in clinical infections, for example, just in America, two Gram-positive bacteria -Pneumococcus and Staphylococcus - are responsible for almost 75% of all the antibiotic usage. Piece researched and written by Catarina Amorim catarina.amorim@linacre.ox.ac.uk

Catarina Amorim | alfa
Further information:
http://emboreports.npgjournals.com
http://www.oct.mct.pt

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
21.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Nagoya physicists resolve long-standing mystery of structure-less transition

21.08.2017 | Materials Sciences

Chronic stress induces fatal organ dysfunctions via a new neural circuit

21.08.2017 | Health and Medicine

Scientists from the MSU studied new liquid-crystalline photochrom

21.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>